Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
04/1993
04/27/1993CA1316915C Macrolide antibiotics and their preparation
04/27/1993CA1316832C Treatment of human viral infection by dsrna combined with viral inhibitors
04/27/1993CA1316649C Moulding contact lenses
04/26/1993CA2081262A1 Acetylene compounds
04/26/1993CA2081050A1 Treponema hyodysenteriae vaccine
04/25/1993WO1993007880A1 Anti-microbial mafenide-phosphanilate compound, pharmaceutical compositions and method of use therefor
04/25/1993CA2098996A1 Anti-microbialmafenide-phosphanilate compound, pharmaceutical compositions and method of use therefor
04/24/1993CA2081134A1 Hiv protease inhibitors
04/23/1993CA2080867A1 Use of substituted pyrrolidines, some of which are known, as medicaments, new active substances and processes for their preparation
04/23/1993CA2080863A1 Use of substituted tetrahydrothiophenes, some of which are known, as medicaments, new active substances and processes for their preparation
04/21/1993EP0538194A1 Bicyclic nucleosides, oligonucleotides, their method of preparation and intermediates therein
04/21/1993EP0538193A2 Condensed cycloaliphatir-amidino-hydrazon salts as S-adenosylmethionin decarboxylase inhibitors
04/21/1993EP0538101A1 Process for the preparation of benzo(b)naphthyridines
04/21/1993EP0538100A1 New fluoro-quinolin-3-carboxylic acid derivatives and their preparation
04/21/1993EP0538027A2 Cyclohexapeptides
04/21/1993EP0538018A1 (N-pyridiniumphenyl)-carbapenems
04/21/1993EP0538017A1 2-(N-Imidazoliumphenyl)-carbapenems
04/21/1993EP0538016A1 MRSA active 2-phenyl-carbapenems
04/21/1993EP0538002A1 Aminoalkyl thioether compounds
04/21/1993EP0538001A1 MRSA active 2-halophenyl carbapenems
04/21/1993EP0537729A1 Pharmaceutical compositions containing triazole derivatives for rectal administration
04/21/1993EP0537622A1 Antifungal agent, its preparation and microorganism therefor
04/21/1993EP0537430A1 Antiviral agents
04/21/1993EP0537326A1 Rna delivery vector
04/21/1993EP0537232A1 Recombinant pigeon pox virus vaccine
04/21/1993EP0537199A1 Compositions for treating hiv-type 1 infection
04/21/1993EP0526570A4 Composition and treatment with biologically active peptides and anti-parasitic agents or anti-fungal agents
04/21/1993EP0343248B1 Novel polypeptide and method for preparing the same
04/21/1993EP0303683B1 Amphotericin b/cholesterol sulfate composition and method
04/21/1993CN1020340C 1-carbacephalosporin antibiotics
04/20/1993US5204466 Stereoselective preparation of biologically active isomer
04/20/1993US5204330 Antifungal compounds
04/18/1993CA2080759A1 Aminoalkylamides
04/18/1993CA2080757A1 Aminoalkyl thioether compounds
04/18/1993CA2080756A1 1-(4-hydroxy-5-aminoethyloxy-n2- (10,12-dimethyl-1-oxotetraecyl) ornithine)-5(3-hydroxyglutamine) -6-(3-hydroxyproline) echinocandin
04/18/1993CA2080640A1 Bicyclic nucleosides, oligonucleotides, process for their preparation and intermediates
04/18/1993CA2080618A1 Mrsa active 2-halophenyl-carbapenems
04/18/1993CA2080617A1 Mrsa active 2-phenyl-carbapenems
04/18/1993CA2080615A1 2-(n-imidazoliumphenyl)-carbapenems
04/18/1993CA2080614A1 (n-pyridiniumphenyl)-carbapenems
04/17/1993WO1993007892A1 Composition and treatment with biologically active peptides and antibiotic
04/17/1993CA2120337A1 Composition and treatment with biologically active peptides and antibiotic
04/15/1993WO1993007283A1 Composition for inserting nucleic acid complexes into higher eucaryotic cells
04/15/1993WO1993007273A1 Helicobacter pylori genes necessary for the regulation and maturation of urease, and use thereof
04/15/1993WO1993007178A1 Oligoside derived from an antigen polyoside obtained from a pathogenic agent
04/15/1993WO1993007172A1 Subunit vaccine for neisseria meningitidis infections and corresponding purified subunits
04/15/1993WO1993007163A1 Chemical compounds
04/15/1993WO1993007157A1 Antiviral acyclic phosphonomethoxyalkyl substituted, alkenyl and alkynyl purine and pyrimidine derivatives
04/15/1993WO1993007154A1 Process for making antimicrobial quinolonyl lactams
04/15/1993WO1993007145A1 METHOD FOR PREPARING BENZO[b]NAPHTHYRIDINES
04/15/1993WO1993007144A1 1,8-benzonaphthyridine derivatives and antimicrobial compositions
04/15/1993WO1993007139A1 Triazole antifungal agents
04/15/1993WO1993007128A1 Cyclic ureas and analogues useful as retroviral protease inhibitiors
04/15/1993WO1993007127A1 New derivatives of fluoro-quinoline carboxylic-3 acid and preparation thereof
04/15/1993WO1993006861A1 Vaccine for neisseria meningitidis infections
04/15/1993WO1993006847A1 Use of ifn-gamma for the treatment of infections in transplant recipients
04/15/1993WO1993006843A1 Peptides corresponding to antigenic determinants of htlv
04/15/1993WO1993006832A1 Method of treating hiv infection
04/15/1993WO1993006822A1 Trimethoprim oral liquid
04/15/1993WO1993001210A3 Hcv peptide-antigens and a method of testing for the hepatitis c virus (hcv)
04/15/1993CA2120925A1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
04/15/1993CA2120493A1 Process for making antimicrobial quinolonyl lactams
04/15/1993CA2120140A1 Method of treating hiv infection
04/15/1993CA2119755A1 1,8-benzonaphtyridine derivatives and antimicrobial compositions
04/15/1993CA2097056A1 Vaccine against neisseria meningitidis infections
04/15/1993CA2096411A1 Subunit vaccine for neisseria meningitidis infections and corresponding purified subunits
04/14/1993EP0536969A2 Anti-endotoxin compounds
04/14/1993EP0536515A1 Novel 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
04/14/1993EP0536299A1 Surface complexed lymphotoxin
04/14/1993EP0536275A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
04/14/1993EP0536234A1 Vectors containing hiv packaging sequences, packaging defective hiv vectors, and uses thereof
04/14/1993EP0536224A1 Antiviral agents containing heteropolytungstate
04/14/1993EP0313651B1 Synthetic peptides for diagnosis and prevention of influenza virus infection and their use
04/14/1993CN1070946A Composition for introducing nucleic acid complexes into higher eucaryotic cells
04/14/1993CN1070909A Thiourea derivatives and antimicrobial agent and antiulcer agent containing same
04/14/1993CN1070906A Substituted aminopropanes, processes for their prepartion and their use
04/13/1993US5202420 Pure genetically engineered peptides which inhibit growth of escherichia
04/13/1993US5202348 Thiarubrine antifungal agents
04/13/1993US5202337 Antibacterial agent, feed additive
04/13/1993US5202315 Antiboiotic
04/13/1993US5202244 Process for producing aphidicolin using the microrganism verticillium sp
04/13/1993CA1316171C Cephalosporin derivatives
04/13/1993CA1316170C Glycosidic derivatives
04/13/1993CA1316110C Sustained release matrix formulations
04/12/1993CA2079971A1 Anti-endotoxin compounds and related molecules and methods
04/10/1993CA2079309A1 Antifungal agent
04/07/1993EP0536035A1 1,8-Benzonaphthyridine derivatives and antimicrobial compositions
04/07/1993EP0535968A1 Cyclohexapeptidyl hydroxypropionitrile compounds
04/07/1993EP0535967A2 Cyclohexapeptidyl bisamine compounds
04/07/1993EP0535959A1 Cyclohexapeptidyl propanolamine compounds
04/07/1993EP0535528A1 Antibacterial 5-Nitro-1-methyl-imidazolyl-3-terbutyl-2-hydroxy-aryl-carbinols
04/07/1993EP0535390A1 The use of L-2-oxothiazolidine-4-carboxylate for the preparation of a medicament for treating latent HIV infection
04/07/1993EP0535346A1 9-amino-7-substituted-6-demethyl-6-deoxytetracyclines
04/07/1993EP0535184A1 Novel quinolones, process for their preparation and pharmaceutical compositions containing same
04/07/1993EP0535092A1 Protease nexin-i variants
04/07/1993EP0535034A1 Pharmaceutically active benzoquinazoline compounds
04/07/1993EP0535021A1 Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome
04/07/1993EP0535001A1 Composite molecular system for the contra-escalatory treatment of viral infections.
04/07/1993EP0513200A4 Method and compositions for the synthesis of bch-189 and related compounds
04/07/1993EP0233936B1 Synthetic polypeptides for detecting mycobacterial infections